These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10686939)

  • 1. Atypical chronic myeloid leukemia with der(20)t(17;20)(q21;q13).
    Ma SK; Wan TS; Au WY; Kwong YL; Chan LC
    Cancer Genet Cytogenet; 1999 Jul; 112(2):130-3. PubMed ID: 10686939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia.
    Nishii K; Usui E; Sakakura M; Miyata E; Ridge SA; Ford AM; Masuya M; Chen F; Mitani H; Yamaguchi M; Katayama N; Kita K; Shiku H
    Cancer Genet Cytogenet; 2001 Apr; 126(1):8-12. PubMed ID: 11343772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transposition of duplicated chromosomal segment involving fused BCR-ABL gene or ABL oncogene alone in chronic myelocytic leukemia and Ph chromosome-positive acute leukemia with complex karyotypes.
    Tanaka K; Arif M; Kyo T; Dohy H; Kamada N
    Cancer Genet Cytogenet; 2000 May; 119(1):8-14. PubMed ID: 10812164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
    Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complex cytogenetic aberrations in a patient with chronic myeloid leukemia: a case report].
    Luk'ianova AS; Pien'kovs'ka-Hrelia B; Masliak ZV
    Tsitol Genet; 2009; 43(3):48-54. PubMed ID: 19938637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional heteromorphism of 9q13 --> q21 in a patient with chronic myelogenous leukemia.
    Surana RB; Rafi SK; Christopher KL; Reid TJ; Weiss RB
    Clin Genet; 1995 Jun; 47(6):321-3. PubMed ID: 7554367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ider(9)(q10)t(9;22)(q34;q11) is a recurrent chromosomal abnormality in acute lymphoblastic leukemia and lymphatic blastic phase of chronic myelogenous leukemia.
    Dierlamm J; Michaux L; Kröger N; Wlodarska I; Martiat P; Zeller W; Seeger D; Mecucci C; van den Berghe H; Hossfeld DK
    Cancer Genet Cytogenet; 1996 Jul; 89(2):109-13. PubMed ID: 8697413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
    Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
    Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
    Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
    Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia.
    Takahashi N; Miura I; Ohshima A; Utsumi S; Nimura T; Hashimoto K; Saito M; Miura AB
    Cancer Genet Cytogenet; 1996 Jul; 89(2):166-9. PubMed ID: 8697426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
    Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
    Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
    Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
    Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
    [No Abstract]   [Full Text] [Related]  

  • 14. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.
    Suzuki K; Sugawara T; Kowata S; Utsugizawa T; Ito S; Murai K; Ishida Y
    Cancer Genet Cytogenet; 2004 Apr; 150(2):159-63. PubMed ID: 15066325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.
    Gadzicki D; von Neuhoff N; Steinemann D; Just M; Büsche G; Kreipe H; Wilkens L; Schlegelberger B
    Cancer Genet Cytogenet; 2005 Jun; 159(2):164-7. PubMed ID: 15899391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral karyotyping refined the identification of a der(Y)t(Y;1)(q11.1 or.2;q12) in the blast cells of a patient with atypical chronic myeloid leukemia.
    Ohsaka A; Hisa T
    Acta Haematol; 2002; 107(4):224-9. PubMed ID: 12053151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid blast crisis during complete cytogenetic remission following interferon-alpha and hydroxyurea therapy.
    Bose S; Chowdhry VP; Saxena R; Kucheria K
    Acta Haematol; 1997; 98(3):155-9. PubMed ID: 9352747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of t(3;3)(q21;q26.2) associated with severe multilineage dysplasia and multi-drug resistance in blastic crisis of chronic myelogenous leukemia].
    Lee SA; Lim J; Kim M; Kim Y; Han K
    Korean J Lab Med; 2010 Dec; 30(6):595-9. PubMed ID: 21157145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11).
    Li L; Ritterbach J; Harbott J; Schroyens W; Lohmeyer J; Pralle H; Lampert F
    Cancer Genet Cytogenet; 1993 Jul; 68(2):131-4. PubMed ID: 8353804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.